Last Week’s Top-3 Most Read Posts On Pulmonary Fibrosis

Read the articles: 1. Potential Therapy for Severe Lung Disease Advances at aTyr Pharma 2. IPF Experts Discuss Disease Diagnosis and Treatment at CHEST 2015 3. Potential IPF Disease Biomarkers Seen in Patients’ Blood  …

Emphysema is a type of lung disease that causes shortness of breath. In a person with emphysema, the alveoli are damaged. The alveoli walls and the elastic fibers are damaged and lost.   Learn more about Emphysema and Pulmonary Fibrosis: https://bit.ly/1ONmRdG…

https://www.youtube.com/watch?v=0mrrh1lcYbY   Learn more about PF: https://bit.ly/1lfMsiZ…

Researchers at the University of Miami (UM), led by Assistant Professor Ashutosh Agarwal, are developing functional organs able to mimic real human organs. These laboratory-developed structures, based on chips, could revolutionize approaches to disease treatment by allowing researchers to peer into organs and their related diseases. The research team used an innovative approach…

Learn more about Pulmonary Fibrosis: https://bit.ly/1lfMsiZ…

The Pulmonary Fibrosis Foundation (PFF) recently announced that its PFF Care Center Network has added 19 new sites, almost double its previous number, and now totals 40 centers across 26 U.S. states. The Network, started in 2013, is a group of leading medical centers with specific expertise in the treatment of pulmonary fibrosis (PF), a…

  Charlie Boone died past Sunday at the age of 88. Boone was the WCCO Radio host who was the voice of mornings in Minnesota for nearly 40 years and one of its stars. “Charlie was one of the greatest talents in the history of radio broadcasting, and…

“Learn what the main classifications of lung diseases are: obstructive, restrictive, ventilation, and perfusion. Discover the classification of common diseases like asthma, emphysema, and pneumonia.”   Learn more about Pulmonary Fibrosis: https://bit.ly/1lfMsiZ…

The recently concluded Pulmonary Fibrosis Foundation (PFF)’s third biennial scientific conference,  Summit 2015: From Bench to Bedside, achieved a record attendance of over 700 people — from pulmonary fibrosis researchers, academics and healthcare specialists to industry front-runners and PF patients/caregivers — representing 18 countries. Attendees presented research and discussed new treatments in a collaborative setting…

Veracyte, Inc.recently presented four abstracts on current diagnostic challenges related to interstitial lung disease (ILD) and the potential for improved diagnostic procedures using novel genomic-based strategies. The abstracts were given at the Pulmonary Fibrosis Foundation’s PFF Summit 2015: From Bench to Bedside at the JW Marriott Hotel…